Sung Lee

EVP, Chief Financial Officer

Sung joined us as Executive Vice President and Chief Financial Officer in May 2024.

Sung is an experienced CFO who brings more than 20 years of finance leadership expertise in the biopharmaceutical and technology businesses to Cytokinetics.  Prior to Cytokinetics, Sung was the CFO at Vir Biotechnology, MorphoSys, and Sangamo Therapeutics. He also spent 14 years at Gilead Sciences, where he served in roles of increasing responsibility and scope, including Senior Vice President, Financial Planning & Analysis and Investor Relations.  Sung began his career in the tax advisory business at PwC.

Sung received a bachelor’s degree in economics from the University of California, Irvine and a Master of Business Taxation degree from the University of Southern California.

Sung is married, a father of two daughters, and has a passion for interior design.  He is also a lifelong LA Dodgers fan.